-
Dual bronchodilation for the treatment of chronic obstructive pulmonary disease: a review of the latest clinical data
Donald Banerji, Robert Fogel & Kai-Michael Beeh
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dual bronchodilation for the treatment of chronic obstructive pulmonary disease: a review of the latest clinical data
Donald Banerji, Robert Fogel & Kai-Michael Beeh
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dual bronchodilation for the treatment of chronic obstructive pulmonary disease: a review of the latest clinical data
Donald Banerji, Robert Fogel & Kai-Michael Beeh
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dual bronchodilation for the treatment of chronic obstructive pulmonary disease: a review of the latest clinical data
Donald Banerji, Robert Fogel & Kai-Michael Beeh
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dual bronchodilation for the treatment of chronic obstructive pulmonary disease: a review of the latest clinical data
Donald Banerji, Robert Fogel & Kai-Michael Beeh
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dual bronchodilation for the treatment of chronic obstructive pulmonary disease: a review of the latest clinical data
Donald Banerji, Robert Fogel & Kai-Michael Beeh
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dual bronchodilation for the treatment of chronic obstructive pulmonary disease: a review of the latest clinical data
Donald Banerji, Robert Fogel & Kai-Michael Beeh
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dual bronchodilation for the treatment of chronic obstructive pulmonary disease: a review of the latest clinical data
Donald Banerji, Robert Fogel & Kai-Michael Beeh
Review: Clinical Trail Outcomes: Clinical Investigation
-
Betamethasone valerate foam: a look at the clinical data
Avner Shemer, Nicole Sakka & Dov Tamarkin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Betamethasone valerate foam: a look at the clinical data
Avner Shemer, Nicole Sakka & Dov Tamarkin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Betamethasone valerate foam: a look at the clinical data
Avner Shemer, Nicole Sakka & Dov Tamarkin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Betamethasone valerate foam: a look at the clinical data
Avner Shemer, Nicole Sakka & Dov Tamarkin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Betamethasone valerate foam: a look at the clinical data
Avner Shemer, Nicole Sakka & Dov Tamarkin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Betamethasone valerate foam: a look at the clinical data
Avner Shemer, Nicole Sakka & Dov Tamarkin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Betamethasone valerate foam: a look at the clinical data
Avner Shemer, Nicole Sakka & Dov Tamarkin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Betamethasone valerate foam: a look at the clinical data
Avner Shemer, Nicole Sakka & Dov Tamarkin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Lost in translation: will the personal become impersonal when conducting research in the age of technology?
Sue M Penckofer
Editorial: Clinical Investigation
-
Lost in translation: will the personal become impersonal when conducting research in the age of technology?
Sue M Penckofer
Editorial: Clinical Investigation
-
Lost in translation: will the personal become impersonal when conducting research in the age of technology?
Sue M Penckofer
Editorial: Clinical Investigation
-
Lost in translation: will the personal become impersonal when conducting research in the age of technology?
Sue M Penckofer
Editorial: Clinical Investigation
-
Lost in translation: will the personal become impersonal when conducting research in the age of technology?
Sue M Penckofer
Editorial: Clinical Investigation
-
Lost in translation: will the personal become impersonal when conducting research in the age of technology?
Sue M Penckofer
Editorial: Clinical Investigation
-
Lost in translation: will the personal become impersonal when conducting research in the age of technology?
Sue M Penckofer
Editorial: Clinical Investigation
-
Lost in translation: will the personal become impersonal when conducting research in the age of technology?
Sue M Penckofer
Editorial: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
Linagliptin tablets first to receive US FDA approval at one dosage strength for Type 2 diabetes treatment
News and Views: Clinical Investigation
-
Linagliptin tablets first to receive US FDA approval at one dosage strength for Type 2 diabetes treatment
News and Views: Clinical Investigation
-
Linagliptin tablets first to receive US FDA approval at one dosage strength for Type 2 diabetes treatment
News and Views: Clinical Investigation
-
Linagliptin tablets first to receive US FDA approval at one dosage strength for Type 2 diabetes treatment
News and Views: Clinical Investigation
-
Linagliptin tablets first to receive US FDA approval at one dosage strength for Type 2 diabetes treatment
News and Views: Clinical Investigation
-
Linagliptin tablets first to receive US FDA approval at one dosage strength for Type 2 diabetes treatment
News and Views: Clinical Investigation
-
Linagliptin tablets first to receive US FDA approval at one dosage strength for Type 2 diabetes treatment
News and Views: Clinical Investigation
-
Linagliptin tablets first to receive US FDA approval at one dosage strength for Type 2 diabetes treatment
News and Views: Clinical Investigation